Connection

Giancarlo Liumbruno to Hemophilia A

This is a "connection" page, showing publications Giancarlo Liumbruno has written about Hemophilia A.
Connection Strength

1.513
  1. The importance of ABO blood group in pharmacokinetic studies in haemophilia A. Haemophilia. 2018 05; 24(3):e122-e123.
    View in: PubMed
    Score: 0.474
  2. Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia. Semin Thromb Hemost. 2018 Sep; 44(6):595-603.
    View in: PubMed
    Score: 0.467
  3. Acquired hemophilia A: a review of recent data and new therapeutic options. Hematology. 2017 Oct; 22(9):514-520.
    View in: PubMed
    Score: 0.449
  4. Factors affecting the quality, safety and marketing approval of clotting factor concentrates for haemophilia. Blood Transfus. 2018 11; 16(6):525-534.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.